Bioorganic and Medicinal Chemistry Letters

trans-2,6-, 3,6- and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[C]phenanthrene-10,11-diols as dopamine agonists
pp. 1341-1346(6)
Authors: Gu Y.G.; Bayburt E.K.; Michaelides M.R.; Lin C.W.; Shiosaki K.

A Highly Stereoselective Synthesis of Plaunotol and Its Thiourea Derivatives as Potent Antibacterial Agents against Helicobacter Pylori
pp. 1347-1350(4)
Authors: Kogen H.; Tago K.; Arai M.; Minami E.; Masuda K.; Akiyama T.

A novel molecular design of thrombin receptor antagonist
pp. 1351-1356(6)
Authors: Fujita T.; Nakajima M.; Inoue Y.; Nose T.; Shimohigashi Y.

Low-molecular-weight anti-HIV-1 peptides from the amino-terminal sequence of rantes: possible lead compounds for coreceptor-directed anti-HIV-1 agents
pp. 1357-1360(4)
Authors: Nishiyama Y.; Murakami T.; Kurita K.; Yamamoto N.

S1319: a novel ₂-adrenoceptor agonist from a marine sponge Dysidea sp.
pp. 1361-1364(4)
Authors: Suzuki H.; Shindo K.; Ueno A.; Miura T.; Takei M.; Sakakibara M.; Fukamachi H.; Tanaka J.; Higa T.

Methionyl Adenylate Analogues as Inhibitors of Methionyl-tRNA Synthetase
pp. 1365-1370(6)
Authors: Lee J.; Kang S.U.; Kang M.K.; Chun M.W.; Jo Y.J.; Kwak J.H.; Kim S.

Synthesis and protein kinase C binding activity of benzolactam-V7
pp. 1371-1374(4)
Authors: Ma D.; Wang G.; Wang S.; Kozikowski A.P.; Lewin N.E.; Blumberg P.M.

Acyl-CoA: cholesterol acyltransferase inhibitory activity of ginseng sapogenins, produced from the ginseng saponins
pp. 1375-1378(4)
Authors: Kwon B.-M.; Kim M.-K.; Baek N.-I.; Kim D.-S.; Park J.-D.; Kim Y.-K.; Lee H.-K.; Kim S.I.

N-Substituted-3-arylpyrrolidines: Potent and Selective Ligands at Serotonin 1A Receptor
pp. 1379-1384(6)
Authors: Ahn K.H.; Lee S.J.; Lee C.-H.; Hong C.Y.; Park T.K.

Efficient inhibition of muscle and liver glycogen phosphorylases by a new glucopyranosylidene-spiro-thiohydantoin
pp. 1385-1390(6)
Authors: Osz E.; Somsak L.; Szilagyi L.; Kovacs L.; Docsa T.; Toth B.; Gergely P.

Short Synthesis and Anti-Rhinoviral Activity of Imidazo[1,2-a]Pyridines: The Effect of Acyl Groups at 3-Position
pp. 1391-1394(4)
Authors: Hamdouchi C.; Ezquerra J.; Vega J.A.; Vaquero J.J.; Alvarez-Builla J.; Heinz B.A.

Novel fluorogenic substrates for acid phosphatase
pp. 1395-1396(2)
Author: Gee K.R.

Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site
pp. 1397-1402(6)
Authors: Vieira E.; Binggeli A.; Breu V.; Bur D.; Fischli W.; Guller R.; Hirth G.; Marki H.P.; Muller M.; Oefner C.; Scalone M.; Stadler H.; Wilhelm M.; Wostl W.

Piperidine-renin inhibitors compounds with improved physicochemical properties
pp. 1403-1408(6)
Authors: Guller R.; Binggeli A.; Breu V.; Bur D.; Fischli W.; Hirth G.; Jenny C.; Kansy M.; Montavon F.; Muller M.; Oefner C.; Stadler H.; Vieira E.; Wilhelm M.; Wostl W.; Marki H.P.

Design, synthesis and structure-activity relationships of novel strychnine-insensitive glycine receptor ligands
pp. 1409-1414(6)
Authors: Cordi A.; Lacoste J.-M.; Audinot V.; Millan M.

Competitive inhibition of a glutamate carboxypeptidase by phosphonamidothionate derivatives of glutamic acid
pp. 1415-1418(4)
Authors: Rodriguez C.E.; Lu H.; Dinh T.T.; Mlodnosky K.L.; Dastgah A.; Lam V.Q.; Nichols C.B.; Berkman C.E.

Enhancing solid phase synthesis by a noncovalent protection strategy-efficient coupling of rhodamine to resin-bound peptide nucleic acids
pp. 1419-1422(4)
Authors: Mayfield L.D.; Corey D.R.

Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists of the thrombin receptor (PAR-1)
pp. 1423-1428(6)
Authors: McComsey D.F.; Hawkins M.J.; Andrade-Gordon P.; Addo M.F.; Oksenberg D.; Maryanoff B.E.

Uncarinic acids: phospholipase C1 inhibitors from hooks of Uncaria Rhynchophylla
pp. 1429-1432(4)
Authors: Lee J.S.; Yang M.Y.; Yeo H.; Kim J.; Lee H.S.; Ahn J.S.

Syntheses of (+/-)-Shinflavanone and Its Structural Analogues as Potent Inhibitors of Bone Resorption Pits Formation
pp. 1433-1436(4)
Authors: Suh H.; Lee S.; Kim N.; Han J.; Kim J.

Asymmetric synthesis of l-azetidine-2-carboxylic acid and 3-substituted congeners-conformationally constrained analogs of phenylalanine, naphthylalanine, and leucine
pp. 1437-1442(6)
Authors: Hanessian S.; Bernstein N.; Yang R.-Y.; Maguire R.

Phosphofurylalanine, a Stable Analog of Phosphohistidine
pp. 1443-1446(4)
Authors: Schenkels C.; Erni B.; Reymond J.-L.

Adenosine-5'-carboxylic acid peptidyl derivatives as inhibitors of protein kinases
pp. 1447-1452(6)
Authors: Loog M.; Uri A.; Raidaru G.; Jarv J.; Ek P.

P₁, P₂'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors
pp. 1453-1458(6)
Authors: Duan J.J.-W.; Chen L.; Xue C.-B.; Wasserman Z.R.; Hardman K.D.; Covington M.B.; Copeland R.R.; Arner E.C.; Decicco C.P.

Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936
pp. 1459-1462(4)
Authors: Sum P.-E.; Petersen P.

The structure-based design and synthesis of selective inhibitors of trypanosoma cruzi dihydrofolate reductase
pp. 1463-1468(6)
Authors: Zuccotto F.; Brun R.; Pacanowska D.G.; Perez L.M.R.; Gilbert I.H.

Metallopeptide approach to the design of biologically active ligands: design of specific human neutrophil elastase inhibitors
pp. 1469-1474(6)
Authors: Shi Y.; Sharma S.

Macrocyclic hexapeptide analogues of the thrombin receptor (PAR-1) activation motif SFLLRN
pp. 1475-1475(1)
Authors: McComsey D.F.; Hecker L.R.; Andrade-Gordon P.; Addo M.F.; Maryanoff B.E.